BioWorld

March 19, 2004

Depomed Preparing NDA With Positive Ciprofloxacin GR Data

Depomed Inc.'s new formulation of ciprofloxacin HCl achieved top-notch results in a Phase III trial of urinary tract infections. (BioWorld Today) Read More

FDA Seeking Industry Input On Improving Medical Applications

Antigenics Pockets $14.25M For Sale Of Feline Leukemia Vaccine

Focusing On MPSS, Lynx Drops Staff By 15 Percent

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for July 2, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 30, 2026

Black wavy lines forming an abstract sound wave.png

Deep brain stimulation from the shallows: tomorrow’s BCI technology?

BioWorld

Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...

AI-generated image for brain organoid neural research

CINP 2026: organoids reveal autism and addiction mechanisms

BioWorld Science

At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...

Handshake, businessmen holding dollar sign, lightbulb

Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal

BioWorld

A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...